Angiocrine Bioscience, Inc. Alternatives & Competitors
12 companies similar to Angiocrine Bioscience, Inc. — Transforming medicine through engineered cellular therapies that restore, regene...
Companies similar to Angiocrine Bioscience, Inc.
Harvard Apparatus Regenerative Technology, Inc.
HRGN is a bioengineering company that is developing next-generation esophageal implants.
Holliston, United States
Bonus Biogroup
Innovation ★ Tissue Engineering ★ Cell Therapy ★ Impact
Israel
Stembio Cell and Tissue Technologies Inc.
Our purpose is to build a leading, focused ATMPs company powered by advanced therapy platf...
Gebze, Turkey
StemSight - Vision Unlimited
Curing blindness with regenerative cell therapies.
Tampere, Finland
Track all Angiocrine Bioscience, Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Minerva Biotechnologies
We see the future first
Waltham, United States
Celularity Inc.
A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectiou...
United States
Cellusion Inc.
Regenerating Human Potential. More Freedom and More Smiles to the World.
Japan
Sana Biotechnology, Inc.
Focused on creating and delivering engineered cells as medicines for patients
Seattle, United States
LUCA Science Inc.
Enabling functional mitochondria as therapeutic agents.
Japan
Rebirthel Co.,Ltd.
An independent biocompany, developing cellular immunotherapies for cancer, based on Kyoto.
Kyoto, Japan
PrimeCell Bioscience, a.s.
Měníme klasické paradigma léčby
Ostrava, Czech Republic
About Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc. is a private, clinical stage engineered cell therapy company that aims to transform medicine through engineered cellular therapies that restore, regenerate, and repair tissues and organs. Founded in 2012 and headquartered in the United States, the company is focused on harnessing the power o...
Cell Therapy, Genetically Modified Cells, Regenerative Medicine, Endothelial Cells, Clinical Stage, Hemato-oncologic Conditions, Immunologic Conditions, Vascular Niche, Stem Cell Therapy, Progenitor Cells, Organ Regeneration, Gene Therapy, Immunotherapy, Engineered Cellular Therapies, Tissue Engineering
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Angiocrine Bioscience, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Angiocrine Bioscience, Inc. on 14 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
